semaglutide trevogrumab GDF8 and activin A blockade protects against GLP-1–induced muscle loss while enhancing fat loss in obese male mice and non-human primates Trevogrumab Explained: The Muscle-Sparing GLP-1
Description
While weight management is important in IBD, GLP-1 medications demand individualized provider assessment of inflammatory status, current therapies, and potential pancreatitis or bowel
It can reduce appetite and is generally safe if used as prescribed by a doctor.
I've been wearing them continuously for about 3 weeks now, and my body has slowly undergone positive changes, almost like the stored fat in my abdomen is gradually disappearing, making my stomach slimmer
New data also shows a reduced rate of cardiovascular problems in some patients
